Bacterial superantigens
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Superantigens (SAgs) are the most powerful T cell mitogens ever discovered. Concentrations of less than 0·1 pg/ml of a bacterial superantigen are sufficient to stimulate the T lymphocytes in an uncontrolled manner resulting in fever, shock and death [1–3]. SAgs bind, as intact molecules to the class II major histocompatibility complex (MHC) antigens expressed on professional antigen presenting cells (APCs) outside the peptide-binding groove then sequentially bind the T cell receptor (TcR) via the variable region of the TcR β-chain [3–6]. Every SAg binds a subset of TcR Vβ domains and as the number of different Vβ regions in the human T cell repertoire is restricted to approximately 50, comprising about 24 major types of Vβ elements, a substantial number of T cells are activated by SAgs. This can be as high as 20% compared with only 1 in 105−106 naive T cells that are responsive to conventional peptide antigen. This results in massive systemic release of pro-inflammatory cytokines, such as tumour necrosis factor-alpha (TNF-α) and interleukin-beta (IL-1β), and T cell mediators, such as IL-2, which can lead to fever and shock [3,5,7,8]. Over the last 4 years the number of known bacterial SAgs has increased sharply, due mainly to various microbial genome sequencing projects [9–14]. There are now 41 bacterial SAgs described in the literature (Table 1) and the number is growing steadily. In addition, a new family of SAg-related proteins has been identified in Staphylococcus aureus that show sequence and structural homology to the ‘classical’ SAgs, but appear to have a quite different role. This review provides a summary of the field to date with some of the more recent discoveries that shed light on the how superantigens are able to trigger such strong T cell responses and the diseases related to SAg intoxication. Functional properties of superantigens and their associated diseases Functional properties of superantigens and their associated diseases SAgs are characterized by their ability to bind both MHC class II molecules and T cell receptors [5,6]. This occurs in a sequential fashion. The sole purpose of SAgs appears to be to bring these two critical molecules together in order to activate as many T cells as possible. The net result is the release of a large and sudden bolus of cytokines which causes the acute condition toxic shock [3,5,7,8] The histocompatibility class II molecule, despite its polymorphism, is the principal cell receptor for all SAgs but the affinity for MHC class II varies depending on the class II molecule and the SAg [15–17]. All SAgs examined so far display higher affinities towards human MHC class II molecules than mouse class II, which explains partly why SAgs are several orders of magnitude more potent on human T cells than mouse T cells. A variety of binding modes exist to both MHC class II and TcR (described in more detail below) which indicates the lengths that the bacteria have gone to target these two critical molecules of the adaptive immune response. The first bacterial SAg was isolated in the late 1960s by Bergdoll and coworkers as a secreted toxin of S. aureus and was named staphylococcal enterotoxins A (SEA) for its potent enterotoxic properties. The staphylococcal enterotoxins (SE) are the causative agent in staphylococcal food poisoning and induce vomiting and diarrhoea within 1–2 h following ingestion. The mitogenic activity of SEs was discovered many years later, but the term ‘superantigen’ was not coined until 1989 when Marrack and coworkers found that the mitogenic activity was a result of a massive expansion of T cells that all shared the same T cell receptor Vβ chain domains [2]. Today, 18 different SEs have been described in the literature (Table 1) and all are potent T cell mitogens with half maximum stimulation values as low as 0·1 pg/ml. The SAg family also includes the S. aureus toxic shock syndrome toxin (TSST) which is the causative agent in toxic shock syndrome [18]. Twelve SAgs have been identified in Group A Streptococci (GAS), predominantly but not exclusively produced by S. pyogenes. These are the streptococcal pyrogenic exotoxins (SPEs) A, C, G-M, the streptococcal superantigen (SSA) and the streptococcal mitogenic exotoxin (SMEZ) 1 and 2. Many new SAgs have been identified by screening the completed S. pyogenes genomes; serotypes M1 (Oklahoma University, USA), M3 and M18 (Rocky Mountain Laboratories, NIH, USA) with conserved sequence motifs [10–13]. The sudden explosion of new superantigen sequences has resulted in confusing nomenclature where some sequences have been given two different names. For example, SPE-K identified in a serotype M3 strain from the United States is identical to SPE-L found in an M3 strain from Japan and an M89 strain from New Zealand [10,19,20]. The superantigen gene spe-l found in an M18 strain from the United States is identical to a gene named spe-m found in New Zealand [13,20]. For the purposes of this review, spe-m* is the g
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Whole genome sequencing of meticillin-resistant Staphylococcus aureus
Kuroda, M., Ohta, T., Uchiyama, I., Baba, T., Yuzawa, H., Kobayashi, I., Cui, L., Oguchi, A., Aoki, K.-I., Nagai, Y., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04403-2 · Cited by 1,961
The Staphylococcal Enterotoxins and Their Relatives
Marrack, P., & Kappler, J. (1990) · Science · doi:10.1126/science.2185544 · Cited by 1,895
Genome and virulence determinants of high virulence community-acquired MRSA
Baba, T., Takeuchi, F., Kuroda, M., Yuzawa, H., Aoki, K.-I., Oguchi, A., Nagai, Y., Iwama, N., Asano, K., Naimi, T., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08713-5 · Cited by 1,370
Exotoxins of Staphylococcus aureus
Dinges, M. M., Orwin, P. M., & Schlievert, P. M. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.1.16 · Cited by 967
Complete genome sequence of an M1 strain of Streptococcus pyogenes
Ferretti, J. J., McShan, W. M., Ajdic, D., Savic, D. J., Savic, G., Lyon, K., Primeaux, C., Sezate, S., Suvorov, A. N., Kenton, S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.071559398 · Cited by 936
Superantigens: Mechanism Of T Cell Stimulation And Role In Immune-Responses
Herman, A. (1991) · Annual Review of Immunology · doi:10.1146/annurev.immunol.9.1.745 · Cited by 794
Toxic Shock Syndrome and Bacterial Superantigens: An Update
McCormick, J. K., Yarwood, J. M., & Schlievert, P. M. (2001) · Annual Review of Microbiology · doi:10.1146/annurev.micro.55.1.77 · Cited by 785
Invasive Group A Streptococcus Infections
Stevens, D. L. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.1.2 · Cited by 710
Jardetzky, T. S., Brown, J. H., Gorga, J. C., Stern, L. J., Urban, R. G., Chi, Y.-I., Stauffacher, C., Strominger, J. L., & Wiley, D. C. (1994) · Nature · doi:10.1038/368711a0 · Cited by 578
Miethke, T., Wahl, C., Heeg, K., Echtenacher, B., Krammer, P. H., & Wagner, H. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.1.91 · Cited by 574
Beres, S. B., Sylva, G. L., Barbian, K. D., Lei, B., Hoff, J. S., Mammarella, N. D., Liu, M.-Y., Smoot, J. C., Porcella, S. F., Parkins, L. D., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152298499 · Cited by 499
Bohach, G. A., Fast, D. J., Nelson, R. D., & Schlievert, P. M. (1990) · Critical Reviews in Microbiology · doi:10.3109/10408419009105728 · Cited by 477
Superantigens interact with MHC class II molecules outside of the antigen groove
Dellabona, P., Peccoud, J., Kappler, J., Marrack, P., Benoist, C., & Mathis, D. (1990) · Cell · doi:10.1016/0092-8674(90)90388-u · Cited by 429
Smoot, J. C., Barbian, K. D., Van Gompel, J. J., Smoot, L. M., Chaussee, M. S., Sylva, G. L., Sturdevant, D. E., Ricklefs, S. M., Porcella, S. F., Parkins, L. D., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.062526099 · Cited by 429
Musser, J. M., Hauser, A. R., Kim, M. H., Schlievert, P. M., Nelson, K., & Selander, R. K. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.7.2668 · Cited by 421
A Human Endogenous Retroviral Superantigen as Candidate Autoimmune Gene in Type I Diabetes
Conrad, B., Weissmahr, R. N., Böni, J., Arcari, R., Schüpbach, J., & Mach, B. (1997) · Cell · doi:10.1016/s0092-8674(00)80338-4 · Cited by 406
Kotb, M., Norrby-Teglund, A., McGeer, A., El-Sherbini, H., Dorak, M. T., Khurshid, A., Green, K., Peeples, J., Wade, J., Thomson, G., et al. (2002) · Nature Medicine · doi:10.1038/nm1202-800 · Cited by 398
Sutkowski, N., Conrad, B., Thorley-Lawson, D. A., & Huber, B. T. (2001) · Immunity · doi:10.1016/s1074-7613(01)00210-2 · Cited by 335
Toxic Shock Syndrome Toxin-1 Complexed with a Class II Major Histocompatibility Molecule HLA-DR1
Kim, J., Urban, R. G., Strominger, J. L., & Wiley, D. C. (1994) · Science · doi:10.1126/science.7997880 · Cited by 302
Crystal structure of staphylococcal enterotoxin B, a superantigen
Swaminathan, S., Furey, W., Pletcher, J., & Sax, M. (1992) · Nature · doi:10.1038/359801a0 · Cited by 300
Crystal structure of a T-cell receptor β-chain complexed with a superantigen
Fields, B. A., Malchiodi, E. L., Li, H., Ysern, X., Stauffacher, C. V., Schlievert, P. M., Karjalainen, K., & Mariuzza, R. A. (1996) · Nature · doi:10.1038/384188a0 · Cited by 283
Fast, D. J., Schlievert, P. M., & Nelson, R. D. (1989) · Infection and Immunity · doi:10.1128/iai.57.1.291-294.1989 · Cited by 272
HLA-DR alleles differ in their ability to present staphylococcal enterotoxins to T cells.
Herman, A., Croteau, G., Sekaly, R. P., Kappler, J., & Marrack, P. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.3.709 · Cited by 251
Toxic shock syndrome toxin 1 as an inducer of human tumor necrosis factors and gamma interferon.
Jupin, C., Anderson, S., Damais, C., Alouf, J. E., & Parant, M. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.3.752 · Cited by 219
T Cell Death and Transplantation Tolerance
Li, X. C., Strom, T. B., Turka, L. A., & Wells, A. D. (2001) · Immunity · doi:10.1016/s1074-7613(01)00121-2 · Cited by 207
Identification and Characterization of Novel Superantigens from Streptococcus pyogenes
Proft, T., Louise Moffatt, S., Berkahn, C. J., & Fraser, J. D. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.1.89 · Cited by 194
Self-citationSuperantigens of Mouse Mammary Tumor Virus
Acha-Orbea, H., & MacDonald, H. R. (1995) · Annual Review of Immunology · doi:10.1146/annurev.iy.13.040195.002331 · Cited by 193
Streptococcal Toxic Shock Syndrome Associated with Necrotizing Fasciitis
Stevens, D. L. (2000) · Annual Review of Medicine · doi:10.1146/annurev.med.51.1.271 · Cited by 193
Binary and ternary complexes between T-cell receptor, class II MHC and superantigen in vitro
Seth, A., Stern, L. J., Ottenhoff, T. H. M., Engel, I., Owen, M. J., Lamb, J. R., Klausner, R. D., & Wiley, D. C. (1994) · Nature · doi:10.1038/369324a0 · Cited by 180
Hudson, K. R., Tiedemann, R. E., Urban, R. G., Lowe, S. C., Strominger, J. L., & Fraser, J. D. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.3.711 · Cited by 175
Self-citationThe Mycoplasma arthritidis T-cell mitogen MAM: a model superantigen
Cole, B. C., & Atkin, C. L. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90125-d · Cited by 164
Interferon-α-Induced Endogenous Superantigen
Stauffer, Y., Marguerat, S., Meylan, F., Ucla, C., Sutkowski, N., Huber, B., Pelet, T., & Conrad, B. (2001) · Immunity · doi:10.1016/s1074-7613(01)00212-6 · Cited by 158
An Epstein-Barr virus-associated superantigen.
Sutkowski, N., Palkama, T., Ciurli, C., Sekaly, R. P., Thorley-Lawson, D. A., & Huber, B. T. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.971 · Cited by 136
Crystal Structure of a Superantigen Bound to the High-Affinity, Zinc-Dependent Site on MHC Class II
Li, Y., Li, H., Dimasi, N., McCormick, J. K., Martinꝉ, R., Schuck, P., Schlievert, P. M., & Mariuzza, R. A. (2001) · Immunity · doi:10.1016/s1074-7613(01)00092-9 · Cited by 135
Williams, R. J., Ward, J. M., Henderson, B., Poole, S., O'Hara, B. P., Wilson, M., & Nair, S. P. (2000) · Infection and Immunity · doi:10.1128/iai.68.8.4407-4415.2000 · Cited by 131
Crystal structure of a superantigen bound to MHC class II displays zinc and peptide dependence
Petersson, K., Håkansson, M., Nilsson, H., Forsberg, G., Svensson, L. A., Liljas, A., & Walse, B. (2001) · The EMBO Journal · doi:10.1093/emboj/20.13.3306 · Cited by 125
Papageorgiou, A. C., Acharya, K. R., Shapiro, R., Passalacqua, E. F., Brehm, R. D., & Tranter, H. S. (1995) · Structure · doi:10.1016/s0969-2126(01)00212-x · Cited by 123
Sundberg, E. J., Li, H., Llera, A. S., McCormick, J. K., Tormo, J., Schlievert, P. M., Karjalainen, K., & Mariuzza, R. A. (2002) · Structure · doi:10.1016/s0969-2126(02)00759-1 · Cited by 123
Mehindate, K., Thibodeau, J., Dohlsten, M., Kalland, T., Sékaly, R., & Mourad, W. M. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.182.5.1573 · Cited by 122
Roussel, A., Anderson, B. F., Baker, H. M., Fraser, J. D., & Baker, E. N. (1997) · Nature Structural Biology · doi:10.1038/nsb0897-635 · Cited by 119
Self-citationStaphylococcal enterotoxins can reactivate experimental allergic encephalomyelitis.
Schiffenbauer, J., Johnson, H. M., Butfiloski, E. J., Wegrzyn, L. R., & Soos, J. M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8543 · Cited by 117
Multiple binding sites for bacterial superantigens on soluble class II MHC molecules
Kozono, H., Parker, D. C., White, J., Marrack, P., & Kappler, J. W. (1995) · Immunity · doi:10.1016/1074-7613(95)90088-8 · Cited by 113
Two Novel Superantigens Found in Both Group A and Group CStreptococcus
Proft, T., Webb, P. D., Handley, V., et al. (2003) · Infection and Immunity · doi:10.1128/iai.71.3.1361-1369.2003 · Cited by 108
Self-citationCharacterization and immunogenicity of pyrogenic mitogens SePE-H and SePE-I of Streptococcus equi
Artiushin, S., Timoney, J. F., Sheoran, A. S., et al. (2002) · Microbial Pathogenesis · doi:10.1006/mpat.2001.0482 · Cited by 97
Tiedemann, R. E., & Fraser, J. D. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.9.3958 · Cited by 93
Self-citationArcus, V. L., Langley, R. J., Proft, T., Fraser, J. D., & Baker, E. N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203914200 · Cited by 83
Self-citationSmoot, L. M., McCormick, J. K., Smoot, J. C., Hoe, N. P., Strickland, I., Cole, R. L., Barbian, K., Earhart, C. A., Ohlendorf, D. H., Veasy, L. G., et al. (2002) · Infection and Immunity · doi:10.1128/iai.70.12.7095-7104.2002 · Cited by 82
Ikebe, T., Wada, A., Inagaki, Y., Sugama, K., Suzuki, R., Tanaka, D., Tamaru, A., Fujinaga, Y., Abe, Y., Shimizu, Y., et al. (2002) · Infection and Immunity · doi:10.1128/iai.70.6.3227-3233.2002 · Cited by 82
Cited by
Immune evasion by staphylococci
Foster, T. J. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1289 · Cited by 1,222
Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat
Zetola, N., Francis, J. S., Nuermberger, E. L., & Bishai, W. R. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70112-2 · Cited by 791
Staphylococcus aureus Toxins and Their Molecular Activity in Infectious Diseases
Oliveira, D., Borges, A., & Simões, M. (2018) · Toxins · doi:10.3390/toxins10060252 · Cited by 485
Normanno, G., La Salandra, G., Dambrosio, A., Quaglia, N. C., Corrente, M., Parisi, A., Santagada, G., Firinu, A., Crisetti, E., & Celano, G. V. (2007) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2006.10.049 · Cited by 349
Adaptive immune cells temper initial innate responses
Dong Kim, K., Zhao, J., Auh, S., Yang, X., Du, P., Tang, H., & Fu, Y.-X. (2007) · Nature Medicine · doi:10.1038/nm1633 · Cited by 348
Metadata
- Authors
- PROFT, T., & FRASER, J. D.
- Venue
- Clinical and Experimental Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-08-19
- Volume
- 133
- Issue
- 3
- Pages
- 299-306
- ISSN
- 0009-9104 (ISSN-L)
- 1365-2249
- OpenAlex
- W3188209924
- Cited by
- 440
- References
- 48
- FWCI
- 8.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.